https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin-induced type 1 diabetes in rats https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45186 Wed 26 Oct 2022 14:26:05 AEDT ]]> Targeting eosinophils in respiratory diseases: biological axis, emerging therapeutics and treatment modalities https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46370 Wed 16 Nov 2022 08:45:58 AEDT ]]> Role of the serine/threonine kinase 11 (Stk11) or liver kinase b1 (lkb1) gene in peutz-jeghers syndrome https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47146 Wed 14 Dec 2022 15:27:38 AEDT ]]> Nanosuspensions - An Update on Recent Patents, Methods of Preparation, and Evaluation Parameters https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53696 Wed 10 Jan 2024 10:48:29 AEDT ]]> Small interfering RNA for cancer treatment: overcoming hurdles in delivery https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43998 Wed 05 Oct 2022 15:10:41 AEDT ]]> Targeting LIN28: A new hope in prostate cancer theranostics https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53314 Tue 21 Nov 2023 12:37:09 AEDT ]]> An overview of vaccine development for COVID-19 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46318 Tue 15 Nov 2022 11:45:52 AEDT ]]> Circadian rhythm disruption and alzheimer's disease: The dynamics of a vicious cycle https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46315 Tue 15 Nov 2022 11:31:55 AEDT ]]> Synthesis and anticancer properties of ‘Azole’ based chemotherapeutics as emerging chemical moieties: A comprehensive review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53392 Thu 23 Nov 2023 13:37:24 AEDT ]]> Beyond the obvious: smoking and respiratory infection implications on Alzheimer's disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38949 Thu 17 Mar 2022 08:49:09 AEDT ]]> Hybrid molecules based on 1,3,5-triazine as potential therapeutics: a focused review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39877 Thu 14 Jul 2022 13:40:35 AEST ]]> Monotherapy of RAAS blockers and mobilization of aldosterone: a mechanistic perspective study in kidney disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46616 Mon 28 Nov 2022 10:47:54 AEDT ]]> Albumin nano-encapsulation of piceatannol enhances its anticancer potential in colon cancer via downregulation of nuclear p65 and HIF-1 alpha https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38456 Fri 17 Sep 2021 15:35:08 AEST ]]> Hydrogel composite containing azelaic acid and tea tree essential oil as a therapeutic strategy for Propionibacterium and testosterone-induced acne https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45754 90%), and negative zeta potential (−1.42 ± 0.25% mV) values. ME hydrogel composite with optimum rheological and textural attributes showed better permeation, retention, and skin-compliant characteristics, vis-a-vis marketed formulation (Aziderm™) when evaluated in Wistar rat skin. In vitro antibacterial efficacy in bacterial strains, i.e., Staphylococcus aureus, Propionibacterium acne, and Staphylococcus epidermidis, was evaluated employing agar well plate diffusion and broth dilution assay. ME hydrogel has shown an increase in zone of inhibition by two folds and a decrease in minimum inhibitory concentration (MIC) by eightfold against P. acnes vis-a-vis AzA. Finally, ME hydrogel composite exhibited a better reduction in the papule density (93.75 ± 1.64%) in comparison to Aziderm™ 72.69 ± 4.67%) on acne as developed in rats by inducing testosterone. Thus, the developed AzA-TTO ME hydrogel composite promises an efficacious and comparatively safer drug delivery system for the topical therapy of acne vulgaris.]]> Fri 04 Nov 2022 10:41:04 AEDT ]]>